This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Chelidonic acid ameliorates atopic dermatitis symptoms through suppression the inflammatory mediators in in vivo and in vitro
Applied Biological Chemistry Open Access 17 February 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Thepen, T. et al. Nat. Biotechnol. 18, 48–51 (2000).
Dorner, A.J. et al. Leukemia 13, 1307–1315 (1999).
Richards, P.J. et al. Rheumatology 38, 818–825 (1999).
Hoch, J.R. et al. Surgery 126, 428–437 ( 1999).
Ingmar, A.F.M. et al. J. Clin. Invest. 97, 331– 338 (1996).
Yoshida, Y. et al. J. Immunol. 161, 5873–5879 (1998).
Baluna R. & Vitetta, E.S. J. Immunother. 22, 41–47 ( 1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McCormick, T., Stevens, S. & Kang, K. Macrophages and cutaneous inflammation. Nat Biotechnol 18, 25–26 (2000). https://doi.org/10.1038/71879
Issue Date:
DOI: https://doi.org/10.1038/71879
This article is cited by
-
Chelidonic acid ameliorates atopic dermatitis symptoms through suppression the inflammatory mediators in in vivo and in vitro
Applied Biological Chemistry (2023)